Compositions and methods for treating rage-associated disorders
CA 2495663 A1 · Owner: Imperial College Of Science, Technology And Medicine · Inventors: Feldman, Jeffrey L.; Foxwell, Brian John Maurice; Brennan, Fionula Mary
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Fusion proteins comprising a Receptor for Advanced Glycation End Products Ligand Binding Element (RAGE-LBE) and an immunoglobulin element are disclosed. Also disclosed are fusion proteins comprising a RAGE-LBE and a dimerization domain. Also disclosed are nucleic acids encoding such fusion proteins and methods for using disclosed nucleic acids and proteins to for example, treat , RAGE-related disorders. Additional compositions and methods are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.